AI has shown great promise in clinical research for pituitary diseases, with prediction models surpassing traditional regression methods in terms of accuracy. However, to translate these findings into real-world clinical care, several critical issues require further validation and attention.
1.Generalizability: Most AI studies have been conducted at single centers, with a limited number of participants. Few studies include diverse, international, multicenter datasets, with representation from more
© 2001-2026 Fundación Dialnet · Todos los derechos reservados